The health effects of vitamin D supplementation: evidence from human studies.
Bouillon R, Manousaki D, Rosen C, Trajanoska K, Rivadeneira F, Richards JB.
Nat Rev Endocrinol. 2022 Feb;18(2):96-110. doi: 10.1038/s41574-021-00593-z. Epub 2021 Nov 23.
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H, Remuzzi G, Rossing P, Schmieder RE, Nowack C, Kolkhof P, Joseph A, Pieper A, Kimmeskamp-Kirschbaum N, Ruilope LM; Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group.
JAMA. 2015 Sep 1;314(9):884-94. doi: 10.1001/jama.2015.10081.
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z, Zhong C.
Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11.
Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial.
Ray KK, Nicholls SJ, Li N, Louie MJ, Brennan D, Lincoff AM, Nissen SE; CLEAR OUTCOMES Committees and Investigators.
Lancet Diabetes Endocrinol. 2024 Jan;12(1):19-28. doi: 10.1016/S2213-8587(23)00316-9. Epub 2023 Dec 4.
Modifying Type of Insulin to Manage Steroid-Induced Hyperglycemia: A Case Report.
Pollock FM.
AACN Adv Crit Care. 2023 Mar 15;34(1):39-46. doi: 10.4037/aacnacc2023222.
Use of cardiac glycosides and risk of glioma.
Seliger C, Meier CR, Jick SS, Uhl M, Bogdahn U, Hau P, Leitzmann MF.
J Neurooncol. 2016 Apr;127(2):321-8. doi: 10.1007/s11060-015-2036-2. Epub 2015 Dec 31.
Hyperglycemia and Diabetes Induced by Glucocorticoids in Nondiabetic and Diabetic Patients: Revision of Literature and Personal Considerations.
Elena C, Chiara M, Angelica B, Chiara MA, Laura N, Chiara C, Claudio C, Antonella F, Nicola G.
Curr Pharm Biotechnol. 2018;19(15):1210-1220. doi: 10.2174/1389201020666190102145305.
The cascade to a serendipitous discovery of lithium-induced nephrogenic diabetes insipidus.
Chandrasekaran PK, Yan Qi OW, O Brien FM.
Asian J Psychiatr. 2021 Dec;66:102884. doi: 10.1016/j.ajp.2021.102884. Epub 2021 Oct 19.
Therapeutic approaches to target inflammation in type 2 diabetes.
Goldfine AB, Fonseca V, Shoelson SE.
Clin Chem. 2011 Feb;57(2):162-7. doi: 10.1373/clinchem.2010.148833. Epub 2010 Nov 22.
Eldecalcitol alleviates diabetic periodontitis by regulating macrophage efferocytosis and polarization via SOCE machinery.
Liu H, Sun C, Jiang Y, Gao R, Ying Q, Li X, Liu H, Guo J, Li M.
Int Immunopharmacol. 2025 Jan 27;146:113894. doi: 10.1016/j.intimp.2024.113894. Epub 2024 Dec 26.
